A Comparison of Results of the US Food and Drug Administration's Mini-Sentinel Program With Randomized Clinical Trials: The Case of Gastrointestinal Tract Bleeding With Dabigatran

Simple item page
dc.contributor.authorSipahi, Ilke
dc.contributor.authorCelik, Seden
dc.contributor.authorTozun, Nurdan
dc.date.accessioned2023-02-21T12:35:54Z
dc.date.available2023-02-21T12:35:54Z
dc.date.issued2014-01-01
dc.description.issue1
dc.description.issueJAN
dc.description.pages150-151
dc.description.volume174
dc.identifier.doi10.1001/jamainternmed.2013.12217
dc.identifier.urihttps://hdl.handle.net/11443/2017
dc.identifier.urihttp://dx.doi.org/10.1001/jamainternmed.2013.12217
dc.identifier.wosWOS:000333046500040
dc.publisherAMER MEDICAL ASSOC
dc.relation.ispartofJAMA INTERNAL MEDICINE
dc.titleA Comparison of Results of the US Food and Drug Administration's Mini-Sentinel Program With Randomized Clinical Trials: The Case of Gastrointestinal Tract Bleeding With Dabigatran
dc.typeArticle

Files

Collections

WOS